Study Says New TB Vaccines Could Save 7.3 Million Lives
New tuberculosis vaccines projected from 2029 could save more than 7 million lives over two decades, Gavi stated on Monday, but only if global supply reaches the countries that need them most.
New tuberculosis vaccines projected from 2029 could save more than 7 million lives over two decades, Gavi stated on Monday, but only if global supply reaches the countries that need them most.
Article outline
- What happened
- The key numbers
- The details
- The bottom line
Key points
- The World Health Organization estimated that it caused 1.23 million deaths in 2024.
- Add ProPakistani to Preferred Sources and see more of our stories in Google Search and Top Stories.
- Add as a preferredSource on Google Follow on Google News Join WhatsApp.
- The only licensed TB vaccine now in employ is the Bacille Calmette-Guérin, or BCG, vaccine.
- The study additionally projected up to $135 billion in economic benefits throughout low- and middle-income countries by mid-century.
Gavi chief Sania Nishtar remarked the new TB vaccines could become the "next blockbuster immunisation tool" if manufacturers and donors ensure enough affordable and predictable supply for high-burden countries.
Tuberculosis remains the world's deadliest infectious disease. The World Health Organization estimated that it caused 1.23 million deaths in 2024. Pakistanis Are Being Prescribed Over Twice the Recommended Medicines.
For context, the only licensed TB vaccine now in employ is the Bacille Calmette-Guérin, or BCG, vaccine. It is more than a century old. While BCG protects infants and young children against severe forms of TB, its effect weakens over time.
Gavi remarked new vaccines under development for adolescents and adults could fill that gap. Its latest analysis discovered that the first of these candidates could prevent up to 7.3 million deaths between 2030 and 2050. Pakistan Sees Sharp Decline in Students Choosing Medicine.
Notably, the study additionally projected up to $135 billion in economic benefits throughout low- and middle-income countries by mid-century.
Nevertheless, Gavi cautioned that financing gaps, uncertain demand and subdued investment could slow vaccine rollout after approval. The alliance remarked it is working with partners now to prepare for timely access and wider uptake once the vaccines are licensed. Stay Connected with ProPakistani. Obtain the latest news and stories wherever you prefer. Follow on Google Discover.
Taken together, the developments around study Says New TB Vaccines Could Save 7.3 Million Lives point to a situation that is still moving, and the coming days should bring more clarity.




